Search
for
Sort by
Research 601–630 of 1000+
- Alopecia Areata: An Update on Treatment Options for Children
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Bullying in persons with skin diseases
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Metabolic, Behavioral, and Reproductive Effects of Vertical Sleeve Gastrectomy in an Obese Rat Model of Polycystic Ovary Syndrome
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Health‐related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
- Prophylaxis and Management of Skin Toxicities
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Oral minoxidil for late alopecia in cancer survivors
- Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study
- Extracellular Vesicles for Regenerative Medicine Applications
- Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia